173 Clinical Trials for: Drug: Ezetimibe, Page 1 of Results

1
Completed
Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects
Condition(s): Pharmacokinetics; Drug Interactions; Hypercholesterolemia; Immunosuppression
2
Completed
Pharmacokinetic Drug Interaction Between Ezetimibe and Tacrolimus After Single Dose Administration in Healthy Subjects
Condition(s): Pharmacokinetics; Drug Interactions; Hypercholesterolemia; Immunosuppression
3
Completed
A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)(COMPLETED)
Condition(s): Hypercholesterolemia; Familial Hypercholesterolemia; Homozygous Sitosterolemia
4
Completed
A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)(COMPLETED)
Condition(s): Hypercholesterolemia; Familial Hypercholesterolemia; Homozygous Sitosterolemia
5
Completed
Evaluation of Potential for Drug Interaction Between SCH 58235 (Ezetimibe) and Pitavastatin (Study P03962)(COMPLETED)
Condition(s): Hypercholesterolemia
6
Active, not recruiting
Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)
Condition(s): Peripheral Arterial Disease
7
Completed
Assessment of Potential Interaction Between Ezetimibe and Rosuvastatin in Healthy Subjects With High Cholesterol (P03317)(COMPLETED)
Condition(s): Hypercholesterolemia; Atherosclerosis
8
Completed
Pharmacokinetic and Pharmacodynamic Interactions Between the Cholesterol-lowering Ezetimibe and the Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz During Chronic Treatment in Healthy Volunteers With Reference to Intestinal Expression of CYP3A4, UGT1A1, ABCB1 and ABCC2
Condition(s): Pharmacokinetics; Drug Interactions; Pharmacodynamics; Intestinal Transporter Expression
9
Not yet recruiting
Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome.
Condition(s): Metabolic Syndrome
10
Completed
A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk
Condition(s): Hypercholesterolemia
11
Completed
A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease
Condition(s): Hypercholesterolemia
12
Recruiting
Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol Targets
Condition(s): Hypercholesterolemia; HIV Infections
13
Recruiting
Can Cholesterol Lowering Drugs Influence Circulating Omega-3 Fatty Acid Levels
Condition(s): Hypercholesterolemia; Hyperlipidemia
14
Completed
Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)
Condition(s): Hypercholesterolemia; Atherosclerosis; Coronary Artery Disease
15
Completed
Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood
Condition(s): Dyslipidemias; Coronary Heart Disease; Combined (Atherogenic) Dyslipidemia; Mixed Dyslipidemia
16
Completed
Comparison of Efficacy and Safety of Ezetimibe or Statin Monotherapy to Co-Administration of Both
Condition(s): Cholesterol, LDL
17
Completed
Efficacy of TAK-475 Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.
Condition(s): Hypercholesterolemia
18
Recruiting
Evaluation of Ezetimibe and Atorvastatin Coadministration Versus Atorvastatin or Rosuvastatin Monotherapy in Japanese Patients With Hypercholesterolemia (Study P06027)
Condition(s): Primary Hypercholesterolemia
19
Completed
Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High Cholesterol
Condition(s): Hypercholesterolemia
20
Active, not recruiting
LDL Receptor Under Ezetimibe and Simvastatin
Condition(s): Healthy Men

Clinical Trials Authorship and Review

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

Page 1 of Clinical Trials for Drug: Ezetimibe, 173 Total Matches

Clinical Trials Authorship and Review